Influence of in vitro maturation of engineered cartilage on the outcome of osteochondral repair in a goat model

This study was designed to determine if the maturation stage of engineered cartilage implanted in a goat model of cartilage injury influences the repair outcome. Goat engineered cartilage was generated from autologous chondrocytes cultured in hyaluronic acid scaffolds using 2 d, 2 weeks or 6 weeks of pre-culture and implanted above hydroxyapatite/hyaluronic acid sponges into osteochondral defects. Control defects were left untreated or treated with cell-free scaffolds. The quality of repair tissues was assessed 8 weeks or 8 months post implantation by histological staining, modified O'Driscoll scoring and biochemical analyses. Increasing pre-culture time resulted in progressive maturation of the grafts in vitro. After 8 weeks in vivo, the quality of the repair was not improved by any treatment. After 8 months, O'Driscoll histology scores indicated poor cartilage architecture for untreated (29.7 ± 1.6) and cell-free treated groups (24.3 ± 5.8). The histology score was improved when cellular grafts were implanted, with best scores observed for grafts pre-cultured for 2 weeks (16.3 ± 5.8). As compared to shorter pre-culture times, grafts cultured for 6 weeks (histology score: 22.3 ± 6.4) displayed highest type II/I collagen ratios but also inferior architecture of the surface and within the defect, as well as lower integration with native cartilage. Thus, pre-culture of engineered cartilage for 2 weeks achieved a suitable compromise between tissue maturity and structural/integrative properties of the repair tissue. The data demonstrate that the stage of development of engineered cartilage is an important parameter to be considered in designing cartilage repair strategies.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

European cells & materials - 23(2012) vom: 05. Apr., Seite 222-36

Sprache:

Englisch

Beteiligte Personen:

Miot, S [VerfasserIn]
Brehm, W [VerfasserIn]
Dickinson, S [VerfasserIn]
Sims, T [VerfasserIn]
Wixmerten, A [VerfasserIn]
Longinotti, C [VerfasserIn]
Hollander, A P [VerfasserIn]
Mainil-Varlet, P [VerfasserIn]
Martin, I [VerfasserIn]

Themen:

9004-61-9
91D9GV0Z28
Collagen Type I
Collagen Type II
Durapatite
Hyaluronic Acid
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 08.08.2012

Date Revised 12.11.2019

published: Electronic

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM216808960